Intracameral injection of bevacizumab for the treatment of neovascular glaucoma

Ophthalmologica

Volumn 226, Issue 2, 2011, Pages 51-56

  Wolf, Armin ^a   Von Jagow, Burkhard ^a,b   Ulbig, Michael ^a   Haritoglou, Christos ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Anterior chamber; Avastin ; Bevacizumab; Eye; Neovascularization; Secondary glaucoma; VEGF

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; IRIS RUBEOSIS; MALE; NEOVASCULAR GLAUCOMA; RETREATMENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTERIOR CHAMBER; ANTIBODIES, MONOCLONAL; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; INJECTIONS, INTRAOCULAR; INTRAOCULAR PRESSURE; IRIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 79955557537     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000327364     Document Type: Article

References (24)

1. Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC: Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001; 108: 1767- 1776, quiz 1777, 1800. (Pubitemid 32905930)
2. Shazly TA, Latina MA: Neovascular glaucoma: Etiology, diagnosis and prognosis. Semin Ophthalmol 2009; 24: 113-121.
3. Aiello LP: Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies. Ophthal Res 1997; 29: 354-362. (Pubitemid 27427368)
4. Aiello LP, Avery RL, Arrigg PG, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Engl J Med 1994; 331: 1480-1487. (Pubitemid 24356306)
5. Aiello LP, Wong JS: Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int 2000; 77:S113-S119.
6. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP: Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998; 105: 232-237. (Pubitemid 28090825)
7. Batioglu F, Astam N, Ozmert E: Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int Ophthalmol 2008; 28: 59-61. (Pubitemid 351308686)
8. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU: Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 2006; 142: 158-160. (Pubitemid 43946796)
9. Davidorf FH, Mouser JG, Derick RJ: Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006; 26: 354-356. (Pubitemid 44318196)
10. Kitnarong N, Chindasub P, Metheetrairut A: Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Adv Ther 2008; 25: 438-443.
11. Wakabayashi T, Oshima Y, Sakaguchi H, et al: Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008; 115: 1571-1580, 1580 e1571-e1573.
12. Luke J, Luke M, Grisanti S: Antiangiogenic treatment for neovascular glaucoma and after filtering surgery (in German). Ophthalmologe 2009; 106: 407-412.
13. Jonas JB, Golubkina L, Libondi T, Rensch F: Intravitreal bevacizumab for neovascular glaucoma. Acta Ophthalmologica 2009; 88:e22-e23.
14. Duane T: Clinical Ophthalmology. New York, Lippincott, Williams & Wilkins, 2001.
15. Photocoagulation treatment of proliferative diabetic retinopathy: The second report of diabetic retinopathy study findings. Ophthalmology 1978; 85: 82-106.
16. Augsburger JJ, Roth SE, Magargal LE, Shields JA: Panretinal photocoagulation for radiation- induced ocular ischemia. Ophthal Surg 1987; 18: 589-593. (Pubitemid 17137576)
17. Magargal LE, Brown GC, Augsburger JJ, Donoso LA: Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology 1982; 89: 780-784. (Pubitemid 12039444)
18. Tasman W, Magargal LE, Augsburger JJ: Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 1980; 87: 400-402. (Pubitemid 10102644)
19. Chalam KV, Gupta SK, Grover S, Brar VS, Agarwal S: Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur J Ophthalmol 2008; 18: 255-262. (Pubitemid 351692186)
20. Ehlers JP, Spirn MJ, Lam A, et al: Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 2008; 28: 696-702. (Pubitemid 351655121)
21. Shen YC, Wang MY, Wang CY, et al: Pharmacokinetics of intracameral voriconazole injection. Antimicrob Agents Chemother 2009; 53: 2156-2157.
22. Shen YC, Wang MY, Wang CY, et al: Clearance of intravitreal voriconazole. Invest Ophthalmol Vis Sci 2007; 48: 2238-2241.
23. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ: Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 2007; 114: 855-859. (Pubitemid 46635858)
24. Krohne TU, Eter N, Holz FG, Meyer CH: Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol 2008; 146: 508-512.